Biotech innovation is revolutionizing the brain ischemia drug market, with companies developing novel compounds that target the disease’s specific mechanisms—from clot formation to neuronal damage. Unlike traditional therapies, these drugs aim to not only dissolve clots but also protect brain cells during ischemia, reducing long-term disability. This focus on biological specificity...
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek